Olbert P - Search Results

1

Application of thalidomide/interleukin-2 in immunochemotherapy-refractory metastatic renal cell carcinoma.

Schrader AJ, Heidenreich A, Hegele A, Olbert P, Ohlmann CH, Varga Z, von Knobloch R, Hofmann R. Schrader AJ, et al. Among authors: olbert p. Anticancer Drugs. 2005 Jun;16(5):581-5. doi: 10.1097/00001813-200506000-00014. Anticancer Drugs. 2005. PMID: 15846124 Clinical Trial.

2

Metastatic non-clear cell renal cell carcinoma: current therapeutic options.

Schrader AJ, Olbert PJ, Hegele A, Varga Z, Hofmann R. Schrader AJ, et al. BJU Int. 2008 Jun;101(11):1343-5. doi: 10.1111/j.1464-410X.2008.07462.x. Epub 2008 Jan 30. BJU Int. 2008. PMID: 18241246 Review.

3

[Gender-specific characteristics and survival of renal cell carcinoma].

Schrader AJ, Sevinc S, Olbert PJ, Hegele A, Varga Z, Hofmann R. Schrader AJ, et al. Among authors: olbert pj. Urologe A. 2008 Sep;47(9):1182, 1184-6. doi: 10.1007/s00120-008-1832-0. Urologe A. 2008. PMID: 18679648 German.

4

Incidence and long-term prognosis of papillary renal cell carcinoma.

Schrader AJ, Rauer-Bruening S, Olbert PJ, Hegele A, Rustemeier J, Timmesfeld N, Varga Z, Hofmann R. Schrader AJ, et al. Among authors: olbert pj. J Cancer Res Clin Oncol. 2009 Jun;135(6):799-805. doi: 10.1007/s00432-008-0515-y. Epub 2008 Nov 21. J Cancer Res Clin Oncol. 2009. PMID: 19023595

5

[Toxicity and efficacy of intermittent docetaxel chemotherapy for hormone refractory prostate cancer].

Olbert PJ, Weil C, Hegele A, Hofmann R, Schrader AJ. Olbert PJ, et al. Aktuelle Urol. 2009 May;40(3):164-8. doi: 10.1055/s-0028-1098888. Epub 2009 Apr 15. Aktuelle Urol. 2009. PMID: 19370533 Clinical Trial. German.

6

Clinical significance of a prostate-specific antigen flare phenomenon in patients with hormone-refractory prostate cancer receiving docetaxel.

Olbert PJ, Hegele A, Kraeuter P, Heidenreich A, Hofmann R, Schrader AJ. Olbert PJ, et al. Anticancer Drugs. 2006 Sep;17(8):993-6. doi: 10.1097/01.cad.0000231468.69535.97. Anticancer Drugs. 2006. PMID: 16940810

7

Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma.

Schrader AJ, Rustemeier J, Rustemeier JC, Timmesfeld N, Varga Z, Hegele A, Olbert PJ, Hofmann R. Schrader AJ, et al. J Cancer Res Clin Oncol. 2009 Dec;135(12):1693-9. doi: 10.1007/s00432-009-0616-2. Epub 2009 Jun 20. J Cancer Res Clin Oncol. 2009. PMID: 19543914

8

Urinary collecting system invasion in renal cell carcinoma: incidence and long-term prognosis.

Schrader AJ, Rustemeier J, Varga Z, Hegele A, Olbert PJ, Frohme C, Hofmann R. Schrader AJ, et al. Int J Urol. 2009 Sep;16(9):718-22. doi: 10.1111/j.1442-2042.2009.02353.x. Epub 2009 Jul 29. Int J Urol. 2009. PMID: 19659680

9

Prospective randomized Phase II trial of pegylated doxorubicin in the management of symptomatic hormone-refractory prostate carcinoma.

Heidenreich A, Sommer F, Ohlmann CH, Schrader AJ, Olbert P, Goecke J, Engelmann UH. Heidenreich A, et al. Among authors: olbert p. Cancer. 2004 Sep 1;101(5):948-56. doi: 10.1002/cncr.20455. Cancer. 2004. PMID: 15329902 Free article. Clinical Trial.

10

Plasma levels of cellular fibronectin in patients with localized and metastatic renal cell carcinoma.

Hegele A, Heidenreich A, Kropf J, von Knobloch R, Varga Z, Hofmann R, Olbert P. Hegele A, et al. Among authors: olbert p. Tumour Biol. 2004 May-Jun;25(3):111-6. doi: 10.1159/000079142. Tumour Biol. 2004. PMID: 15361707

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters